BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2005
View Archived Issues
Ligand updates progress of Targretin SPIRIT I and II trials
Read More
GB Therapeutics acquires CHF-1512 for Parkinson's disease
Read More
New phase III study investigates telavancin for hospital-acquired pneumonia
Read More
StaphVAX MAA accepted for review in Europe
Read More
FDA clears phase I trials to begin with human hookworm vaccine
Read More
LL-2113AD shows promise as add-on therapy for type 2 diabetes
Read More
First data on the benefits of letrozole as adjuvant therapy for early breast cancer
Read More
StreptAvax vaccine induces immune response to streptococcal antigens in healthy volunteers
Read More
Cytotoxic drugs reported to increase the antitumor effects of gene vaccines in a breast cancer model
Read More
Good safety profile found for KUR-1246 in pregnant sheep
Read More
Aradigm closes restructured licensing agreement with Novo Nordisk
Read More
Phenoxodiol receives fast track status for hormone-refractory prostate cancer
Read More
Norditropin NordiFlex now available in U.S.
Read More
Enrollment completed in phase III psoriasis trial for ISA-247
Read More
Pivotal study evaluates Acapodene for prostate cancer prevention
Read More
AL-108 enters phase I trials for Alzheimer's disease
Read More
UroGene to sell to Pierre Fabre uro-oncology programs, research platform
Read More
iNOS inhibitor, GW-274150, is protective in experimental colitis
Read More
New title added to the Drug R&D Backgrounders topic list - Scleroderma
Read More
Bemiparin is effective in a mouse asthma model
Read More
Novartis researchers claim PPAR modulators
Read More
Pfizer team describes novel series of PPARalpha activators
Read More
Lysophospholipid EDG receptor agonists disclosed in patents
Read More
Small-particle suspensions of anticonvulsant, antidementia and immunosuppressive agents
Read More
New combinations comprising modafinil reported by Cephalon
Read More
Kissei prepares and tests new agents for hyperuricemia
Read More
A novel series of immunosuppressants described in patent literature
Read More
Further data on use of Rho kinase inhibitor Y-27632 in hypertension
Read More
